{"id":"CHEMBL1079742","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl","inchiKey":"GTTBEUCJPZQMDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOTINIB HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL553","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erlotinib hydrochloride","Tarceva"],"synonyms":["CP-358","CP-358,774-01","CP-358774-01","Erlotinib hydrochloride","OSI-774"],"crossReferences":{"DailyMed":["erlotinib%20hydrochloride"],"PubChem":["534851"],"chEBI":["53509"]},"count":49,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["MONDO_0044926","EFO_0000365","EFO_0000571","EFO_0000681","MONDO_0045056","EFO_0000756","EFO_1000657","EFO_0000308","EFO_1001951","EFO_0000588","MONDO_0002974","MONDO_0003268","Orphanet_733","MONDO_0008903","EFO_0000182","MONDO_0020634","EFO_0002618","MONDO_0008170","MONDO_0008315","MONDO_0002691","EFO_0005567","EFO_0001422","EFO_0005537","EFO_0000233","EFO_0006544","EFO_1000142","EFO_1000172","EFO_0000292","EFO_1001465","MONDO_0007254","EFO_0000708","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0001187","EFO_1000044","MONDO_0002158","EFO_0002499","EFO_1000158","EFO_0000616","EFO_0006859","MONDO_0007576","MONDO_0000521","EFO_0000313","EFO_0002501","EFO_0003060","EFO_0000311","EFO_0000640","MONDO_0002529","MONDO_0011962","MONDO_0002367","EFO_0003833","EFO_0000691","EFO_0003050","EFO_0000519","MONDO_0024880","EFO_0000181","MONDO_0021637"],"count":58},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 49 investigational indications."}
{"id":"CHEMBL1083993","canonicalSmiles":"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.Cl","inchiKey":"ITPDYQOUSLNIHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIODARONE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL633","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amidox","Amiodarone hydrochloride","Amyben","Cordarone","Cordarone x","Cordarone x 100","Cordarone x 200","Darmil","Nexterone","Pacerone"],"synonyms":["Amiodarone","Amiodarone hydrochloride","L-3428","NSC-85442","SK&F-33134-A","SKF 33134-A","SKF-33134-A"],"crossReferences":{"DailyMed":["amiodarone%20hydrochloride"],"PubChem":["144207027","144210713","26747445","50105848","50105849","50105850","552042","56422901","855533"]},"count":6,"approvedIndications":["EFO_0004287","EFO_0005306"],"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004287","EFO_0005306","EFO_0003144","EFO_0005529","Orphanet_85443"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for ventricular tachycardia and ventricular fibrillation and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL110458","canonicalSmiles":"OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"LXBIFEVIBLOUGU-DPYQTVNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGALASTAT","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["At-1001, gr-181314a","Galafold"],"synonyms":["Migalastat"],"crossReferences":{"DailyMed":["migalastat%20hydrochloride"],"PubChem":["11114003"],"drugbank":["DB05018"]},"childChemblIds":["CHEMBL2107355"],"count":1,"linkedTargets":{"rows":["ENSG00000102393"],"count":1},"linkedDiseases":{"rows":["Orphanet_324"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and has 1 investigational indication."}
{"id":"CHEMBL11471","canonicalSmiles":"CC(=N)NCCC[C@H](N)C(=O)O","inchiKey":"UYZFAUAYFLEHRC-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-NIO","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111337","11113558"],"drugbank":["DB03305"]},"childChemblIds":["CHEMBL1256394"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1169388","canonicalSmiles":"CNCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-Fluoxetine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Fluoxetine"],"crossReferences":{"PubChem":["11111168","11111169","11111170","11112803","11113795","124880077","50100239","50111077","90341706"],"drugbank":["DB08544"],"chEBI":["86992"]},"childChemblIds":["CHEMBL1257031"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173055","canonicalSmiles":"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1","inchiKey":"HMABYWSNWIZPAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AG-014699","AG-14447","Rucaparib"],"crossReferences":{"DailyMed":["rucaparib%20camsylate"],"PubChem":["103905261","137276017","174006354"],"drugbank":["DB12332"]},"childChemblIds":["CHEMBL2105733","CHEMBL3833368"],"count":18,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","EFO_0002618","Orphanet_145","EFO_0001075","MONDO_0008170","MONDO_0007254","MONDO_0002087","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0001056","MONDO_0002158","EFO_0000588","EFO_0000564","MONDO_0002974","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_0000673","EFO_1000613"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for cancer and neoplasm and has 16 investigational indications."}
{"id":"CHEMBL117869","canonicalSmiles":"COC(=O)c1c(O)cccc1OC/C=C/c1ccc(F)c(-c2cc(C(=O)O)no2)c1","inchiKey":"QKHWJUMLYAYZFS-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL117869","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198130","canonicalSmiles":"CC[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"OTYYXGRJXJFTCD-KGLIPLIRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198130","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06878"]},"childChemblIds":["CHEMBL596780"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200358","canonicalSmiles":"O=C([O-])Cc1ccccc1.[Na+]","inchiKey":"HZOREEUASZHZBI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHENYLACETATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-3039","Sodium phenylacetate"],"crossReferences":{"DailyMed":["sodium%20phenylacetate"],"PubChem":["538568"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL1200443","drugType":"Small molecule","blackBoxWarning":false,"name":"MERETHOXYLLINE PROCAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Merethoxylline procaine","Procaine merethoxylline"],"crossReferences":{"DrugCentral":["4992"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200563","canonicalSmiles":"COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+]","inchiKey":"GPUADMRJQVPIAS-QCVDVZFFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CERIVASTATIN SODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1477","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Musculoskeletal toxicity"," Nephrotoxicity"],"year":2001},"tradeNames":["Baycol"],"synonyms":["BAY W 6228","Cerivastatin sodium"],"crossReferences":{"PubChem":["144205797","170465109","251919809","49681715"],"chEBI":["3559"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in United States  in 2001 due to Musculoskeletal toxicity and  Nephrotoxicity."}
{"id":"CHEMBL1200762","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PLCQGRYPOISRTQ-LWCNAHDDSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE SODIUM PHOSPHATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201207","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betam-ophtal","Betamethasone sodium phosphate","Betnesol","Betnesol-n","Celestone","Vistamethasone","Vistamethasone n"],"synonyms":["Betamethasone 21-phosphate disodium salt","Betamethasone sodium phosphate","NSC-90616"],"crossReferences":{"DailyMed":["betamethasone%20sodium%20phosphate"],"PubChem":["144212784"],"chEBI":["3078"]},"count":9,"approvedIndications":["EFO_0000729","HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0030838","HP_0003418","HP_0001742","HP_0004798","EFO_1001097","HP_0006536","EFO_0002506","HP_0030833","EFO_0000676","HP_0003419","EFO_0009552","EFO_1001434","EFO_0005752"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 5 approved and 4 investigational indications."}
{"id":"CHEMBL1200826","canonicalSmiles":"O=C([O-])[O-].[Li+].[Li+]","inchiKey":"XGZVUEUWXADBQD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CARBONATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camcolit 250","Camcolit 400","Eskalith","Eskalith cr","Liskonum","Lithane","Lithium carbonate","Lithobid","Lithonate","Lithotabs","Phasal"],"synonyms":["CP-15,467-61","CP-15467-61","CP-1546761","Lithium carbonate","NSC-16895"],"crossReferences":{"DailyMed":["lithium%20carbonate"],"DrugCentral":["4207"],"PubChem":["8139879"],"Wikipedia":["Lithium_carbonate"],"drugbank":["DB14509"],"chEBI":["6504"]},"count":32,"approvedIndications":["EFO_0000289","EFO_0005407"],"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["Orphanet_98755","Orphanet_282","EFO_0000637","MONDO_0002009","EFO_0004216","EFO_1001901","HP_0000726","EFO_0000249","EFO_0003015","EFO_1001919","EFO_0004698","EFO_0003829","HP_0100543","EFO_0000289","EFO_0003931","MONDO_0002050","Orphanet_683","EFO_0000712","MONDO_0001657","EFO_0009854","EFO_0000253","MONDO_0015277","EFO_0005230","EFO_0000692","EFO_1000158","EFO_0003756","Orphanet_646","Orphanet_98757","Orphanet_98756","HP_0001919","EFO_0002508","EFO_1002017","EFO_0009963","EFO_0005407","MONDO_0008315","EFO_1001050","EFO_0003885","Orphanet_399","EFO_0000764","EFO_0000702","Orphanet_278","MONDO_0043510"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for psychosis and bipolar disorder and has 30 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200910","canonicalSmiles":"CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1","inchiKey":"JFNWFXVFBDDWCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE ACETYL","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gantrisin","Gantrisin pediatric","Lipo gantrisin"],"synonyms":["Acetylsulfisoxazole","Sulfisoxazole acetyl"],"crossReferences":{"DailyMed":["sulfisoxazole%20acetyl"],"PubChem":["170465159"],"drugbank":["DB14033"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1200949","canonicalSmiles":"Cl.NCCc1cc[nH]n1","inchiKey":"HLJRAERMLKNULP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAZOLE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201323","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histalog"],"synonyms":["Ametazole","Betazole hydrochloride","Betazolium chloride"],"crossReferences":{"PubChem":["144204280","170465002","56463652"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200979","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCCO","inchiKey":"SNPLKNRPJHDVJA-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPANTHENOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D-panthenol 50","Ilopan","Motilyn"],"synonyms":["(+)-panthenol","D-panthenol","D-pantothenyl alcohol","Dexpanthenol","Pantothenol"],"crossReferences":{"DailyMed":["dexpanthenol"],"PubChem":["170464647"],"Wikipedia":["Panthenol"],"drugbank":["DB09357"],"chEBI":["27373"]},"count":6,"approvedIndications":["EFO_0003966","HP_0200042"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for skin ulcer and eye disease and has 4 investigational indications."}
{"id":"CHEMBL1201248","canonicalSmiles":"COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC","inchiKey":"YXSLJKQTIDHPOT-LJCJQEJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CISATRACURIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nimbex"],"synonyms":["Cisatracurium"],"crossReferences":{"DailyMed":["cisatracurium%20besylate"],"Wikipedia":["Cisatracurium_besilate"],"drugbank":["DB00565"]},"childChemblIds":["CHEMBL1200641"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0000694","EFO_1000992","MONDO_0100130","EFO_1001905","EFO_0005323","EFO_1000637","EFO_0003843"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995."}
{"id":"CHEMBL1201468","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROGENS, ESTERIFIED","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amnestrogen","Esterified estrogens","Estratab","Evex","Femogen","Menest"],"synonyms":["Estrogens esterified","Estrogens, esterified"],"crossReferences":{"DailyMed":["estrogens,%20esterified"]},"count":2,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201718","drugType":"Enzyme","blackBoxWarning":false,"name":"HYALURONIDASE (HUMAN RECOMBINANT)","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cumulase","Hylenex","Hylenex recombinant"],"synonyms":["Hyaluronidase (human recombinant)","Hyaluronidase recombinant human","RHUPH-20","RHUPH20","Vorhyaluronidase alfa"],"crossReferences":{"DailyMed":["hyaluronidase%20(human%20recombinant)","hyaluronidase%20recombinant%20human"]},"count":16,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 16 investigational indications."}
{"id":"CHEMBL1201772","canonicalSmiles":"CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2","inchiKey":"DTGLZDAWLRGWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PRASUGREL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efient"],"synonyms":["LY-640315","Prasugrel"],"crossReferences":{"DailyMed":["prasugrel%20hydrochloride"],"PubChem":["124899264","174006898"],"Wikipedia":["Prasugrel"],"drugbank":["DB06209"],"chEBI":["87723"]},"childChemblIds":["CHEMBL1201773"],"count":10,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","Orphanet_232","EFO_0000275","EFO_0001645","EFO_0000319","EFO_0003913","EFO_0003106","HP_0100806","EFO_0008585","MONDO_0100096","EFO_0003870","EFO_0000270","EFO_0000764","EFO_0003884","EFO_0008583","EFO_0007328","EFO_0000612","EFO_1001207","HP_0004419","EFO_0000400","EFO_0005672"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for recurrent thrombophlebitis and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1220","canonicalSmiles":"CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C","inchiKey":"HJLSLZFTEKNLFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TINIDAZOLE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fasigyn","Symplotan","Tindamax","Tinidazole","Trimonase"],"synonyms":["CP-12,574","CP-12574","Tinidazole"],"crossReferences":{"DailyMed":["tinidazole"],"PubChem":["11112651","144204137","170465196","56422390","855690"],"Wikipedia":["Tinidazole"],"drugbank":["DB00911"],"chEBI":["63627"]},"count":7,"approvedIndications":["EFO_0000771","EFO_0003932"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for bacterial vaginosis and bacterial disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1231606","canonicalSmiles":"COc1cccc(Cc2c[nH]c3ncccc23)c1","inchiKey":"GHQCCHWTDLTMJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231606","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232381","canonicalSmiles":"C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O","inchiKey":"AUTOLBMXDDTRRT-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193703"],"drugbank":["DB03775"],"chEBI":["42280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234354","canonicalSmiles":"COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1","inchiKey":"XDLYKKIQACFMJG-WKILWMFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04691502","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04691502","PF-4691502","Pf-04691502"],"crossReferences":{"drugbank":["DB11974"]},"count":3,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1236282","canonicalSmiles":"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1","inchiKey":"OTVAEFIXJLOWRX-NXEZZACHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMPHENICOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Thiocymetin"],"synonyms":["Dextrosulphenidol","NSC-522822","Thiamphenicol","Thiamphenicol aminoacetate hydrochloride","Thiophenicol","WIN 5063-2","WIN-5063-2"],"crossReferences":{"PubChem":["144204128","144208014","170465845","56320856"],"Wikipedia":["Thiamphenicol"],"drugbank":["DB08621"],"chEBI":["32215"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1256841","canonicalSmiles":"O=C(CCNNC(=O)c1ccncc1)NCc1ccccc1","inchiKey":"NOIIUHRQUVNIDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIALAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1974},"tradeNames":[],"synonyms":["Nialamide"],"crossReferences":{"PubChem":["11111522","11111523","144203759","170466097","50104074","56422110","85231151","855800","90341025"],"drugbank":["DB04820"]},"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in United Kingdom and  United States initially in 1974 due to Hepatotoxicity."}
{"id":"CHEMBL126159","canonicalSmiles":"COc1cc2c3c(n(CCCNCCO)c(=O)c2cc1OC)-c1cc2c(cc1C3=O)OCO2","inchiKey":"QCSDJDQOJBQTDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LMP-744","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lmp-744","Lmp744","MJ-III-65","NSC-706744"],"childChemblIds":["CHEMBL332003"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1318150","canonicalSmiles":"CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12)c1ccc(O)cc1","inchiKey":"BHELIUBJHYAEDK-OAIUPTLZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPOXICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspoxicillin"],"crossReferences":{"PubChem":["144206363","50125944"],"drugbank":["DB13816"],"chEBI":["31240"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1361347","canonicalSmiles":"CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"LBXHRAWDUMTPSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aquex"],"synonyms":["Chlosudimeprimylum","Clopamide","DT-327"],"crossReferences":{"PubChem":["14743456","26750017","50086820"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL139","canonicalSmiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl","inchiKey":"DCOPUUMXTXDBNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cambia","Voltaren","Voltaren Ophthalmic","Voltaren Xr","Zorvolex","Zorvolex capsules"],"synonyms":["Arthrotec","Cataflam","Diclofenac","LAS-41007","LAS41007","Las41007","Solaraze","Voltaren","Voltaren-XR"],"crossReferences":{"DailyMed":["diclofenac","diclofenac%20epolamine","diclofenac%20potassium","diclofenac%20sodium"],"PubChem":["24424557"],"TG-GATEs":["19"],"Wikipedia":["Diclofenac"],"drugbank":["DB00586"],"chEBI":["47381"]},"childChemblIds":["CHEMBL1201180","CHEMBL3350449","CHEMBL1034","CHEMBL1200804"],"count":24,"approvedIndications":["HP_0002829","HP_0003326","EFO_0002506","EFO_0003843","EFO_0005752","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1001139","EFO_1000752","EFO_0004274","MONDO_0002959","EFO_0003964","EFO_0003103","EFO_0002506","EFO_0009560","EFO_0000544","EFO_1001366","EFO_1000786","EFO_0009582","EFO_0004616","EFO_1000652","HP_0003419","HP_0012532","EFO_0003821","EFO_0010072","EFO_1001466","EFO_0002496","EFO_0000546","MP_0001914","MP_0001845","GO_0007568","HP_0003326","HP_0003401","HP_0030833","HP_0100607","MONDO_0002258","EFO_1001434","HP_0004418","EFO_0002970","MONDO_0003005","HP_0002373","EFO_0000278","MONDO_0007254","MONDO_0001370","MONDO_0001187","HP_0002829","MONDO_0002050","EFO_1001216","EFO_0004272","EFO_0004193","HP_0100749","EFO_0009321","EFO_0005752","EFO_0000616","MONDO_0021440","EFO_0000685","EFO_0000545","EFO_0009816","HP_0001945","EFO_0003898","EFO_0003958","EFO_0000313","EFO_0003843","EFO_0005755","HP_0002315","EFO_0009454","EFO_1001412","HP_0030839","EFO_0000649","EFO_0003827"],"count":63},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 6 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1408759","canonicalSmiles":"Cc1ccc(C(C)C)cc2c(C)ccc1-2","inchiKey":"FWKQNCXZGNBPFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUAIAZULEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guaiazulen","Guaiazulene"],"crossReferences":{"PubChem":["170465862","26749853","29215182","93576737"],"drugbank":["DB13329"],"chEBI":["5550"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1423","canonicalSmiles":"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"YVUQSNJEYSNKRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMOZIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orap","Pimozide"],"synonyms":["MCN-JR-6238","NSC-170984","Pimozide","R 623","R 6238","R-623","R-6238"],"crossReferences":{"DailyMed":["pimozide"],"PubChem":["104171210","11111615","11112507","11113804","124881071","124881072","124881075","124881079","144116849","144203775","144211903","170464864","26747138","26751488","26751978","26751979","50104653","563187","56422165","85231181","855710","90341263"],"Wikipedia":["Pimozide"],"drugbank":["DB01100"],"chEBI":["8212"]},"count":7,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000169676"],"count":6},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0004895","EFO_0000253","EFO_0005407","EFO_0005230","EFO_0000692","EFO_0005411"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for psychosis and has 6 investigational indications."}
{"id":"CHEMBL1443577","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1","inchiKey":"XOXHILFPRYWFOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACHLORPYRIDAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nefrosul","Sonilyn"],"synonyms":["Sulfachloropyridazine","Sulfachlorpyridazine","Sulphachlorpyridazine"],"crossReferences":{"PubChem":["11112212","144206510","170466574","26661030","26748511"],"drugbank":["DB11461"],"chEBI":["59057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1476500","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"RXZBMPWDPOLZGW-HITVVWEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1476500","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204248","144206701","144212152","50086576"],"drugbank":["DB00778"],"chEBI":["48844"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL149082","canonicalSmiles":"NCCCS(=O)(=O)O","inchiKey":"SNKZJIOFVMKAOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMIPROSATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acamprosate related compound a","NC-758","NSC-77071","Tramiprosate"],"crossReferences":{"PubChem":["8139961","90340792"],"Wikipedia":["Homotaurine"],"drugbank":["DB06527"],"chEBI":["1457"]},"childChemblIds":["CHEMBL1256473","CHEMBL1256024"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1515","canonicalSmiles":"Cn1cc[nH]c1=S","inchiKey":"PMRYVIKBURPHAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIMAZOLE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Favistan","Methimazole","Tapazole"],"synonyms":["Methimazole","NSC-38608","Thiamazole"],"crossReferences":{"DailyMed":["methimazole"],"PubChem":["11112158","144203892","144208539","144210850","170464856","57299280","8139973"],"TG-GATEs":["57"],"Wikipedia":["Methimazole"],"drugbank":["DB00763"],"chEBI":["50673"]},"count":4,"approvedIndications":["HP_0000820"],"linkedTargets":{"rows":["ENSG00000115705"],"count":1},"linkedDiseases":{"rows":["EFO_0000398","EFO_1001062","EFO_1001466","EFO_0000519","EFO_0004237","HP_0000820"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for abnormality of the thyroid gland and has 3 investigational indications."}
{"id":"CHEMBL1525","canonicalSmiles":"CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1","inchiKey":"RLLPVAHGXHCWKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERMETHRIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elimite","Lyclear","Lythrin","Permethrin"],"synonyms":["Permethrin"],"crossReferences":{"DailyMed":["permethrin"],"PubChem":["144205180","144208784","144211008","26754481","26754482","26754483","26754484","29215320","57260102"],"Wikipedia":["Permethrin"],"drugbank":["DB04930"],"chEBI":["34911"]},"count":3,"approvedIndications":["EFO_0001067"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for parasitic infection and has 2 investigational indications."}
{"id":"CHEMBL1528","canonicalSmiles":"[F-].[Na+]","inchiKey":"PUZPDOWCWNUUKD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FLUORIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dentiplus","Duraphat","En-de-kay","Fluor ret","Fluor-a-day","Fluorigard","Fluorigard daily","Fluorigard weekly","Fluorinse","Minute-gel","Nafril ret","Neutra care","Ossin","Osteofluor","Pediaflor","Point-two","Zymafluor"],"synonyms":["NSC-77385","Sodium Fluoride","Sodium fluoride"],"crossReferences":{"DrugCentral":["4243"],"Wikipedia":["Sodium_fluoride"],"drugbank":["DB09325"],"chEBI":["28741"]},"childChemblIds":["CHEMBL1200744"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 10 investigational indications."}
{"id":"CHEMBL1560","canonicalSmiles":"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FAKRSMQSSFJEIM-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CAPTOPRIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acepril","Capoten","Captomex","Captopril","Ecopace","Hyteneze 12.5","Hyteneze 25","Hyteneze 50","Kaplon","Lopril","Noyada","Tensobon"],"synonyms":["C09AA01","Capoten","Captopril","SA-333","SQ -14225","SQ 14,225","SQ-14225"],"crossReferences":{"DailyMed":["captopril"],"PubChem":["11110941","144204441","170464644","26747043","26751563","50104171","50104172","50104173","50104174","56422201","855925","90340865"],"TG-GATEs":["94"],"Wikipedia":["Captopril"],"drugbank":["DB01197"],"chEBI":["3380"]},"count":13,"approvedIndications":["EFO_0003144","EFO_0000401","EFO_0000373","EFO_0000612","EFO_0003770","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0001361","EFO_0003777","EFO_0000401","EFO_0000373","EFO_0000319","EFO_0000266","EFO_0003770","EFO_0000537","EFO_0003106","MONDO_0100096","EFO_0003144","EFO_0000612","EFO_0001360","EFO_0000668","EFO_0000519","EFO_1000635"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 7 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL15844","canonicalSmiles":"c1ccc2[nH]ccc2c1","inchiKey":"SIKJAQJRHWYJAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole"],"crossReferences":{"PubChem":["144206089","144208875","144213254","170465733"],"Wikipedia":["Indole"],"drugbank":["DB04532"],"chEBI":["16881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591365","canonicalSmiles":"COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1","inchiKey":"VPHPQNGOVQYUMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIRANAFTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Liranaftate"],"crossReferences":{"PubChem":["144205776","170466057","174007142","26758023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL16081","canonicalSmiles":"CC(N)=O","inchiKey":"DLFVBJFMPXGRIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetamide"],"crossReferences":{"PubChem":["11110709","144211093","50105717","50105718","85230893","90341044"],"Wikipedia":["Acetamide"],"drugbank":["DB02736"],"chEBI":["27856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1622","canonicalSmiles":"Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1","inchiKey":"OVBPIULPVIDEAO-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bio science","Folic acid","Folicare","Folicet","Folsan","Folvite","Lexpec","Natur flow","Preconceive","Roche","Vitamin Bc","Vitamin M"],"synonyms":["B03BB01","Folacin","Folic Acid","Folic acid","NSC-3073","Pteroylglutamic acid"],"crossReferences":{"DailyMed":["folic%20acid"],"PubChem":["11112150","144205112","144210447","170464833","26754169","50085945"],"Wikipedia":["Folic_acid"],"drugbank":["DB00158"],"chEBI":["27470"]},"childChemblIds":["CHEMBL2107429"],"count":63,"approvedIndications":["EFO_0003884","EFO_0004272","EFO_0003761","EFO_0001360","EFO_0003882","EFO_0003894","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 8 approved and 55 investigational indications."}
{"id":"CHEMBL1649931","canonicalSmiles":"CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1","inchiKey":"QETUKYDWZIRTEI-QUMGSSFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-232798","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-232798","Pf-00232798","Pf-232798"],"crossReferences":{"drugbank":["DB14813"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1683544","canonicalSmiles":"C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@H]3[C@H](C[C@H]4O[C@@H](CC[C@@H]1O2)C[C@@H](C)C4=C)O[C@H](C[C@H](O)CN)[C@@H]3OC.CS(=O)(=O)O","inchiKey":"QAMYWGZHLCQOOJ-WRNBYXCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERIBULIN MESYLATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1683590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halaven"],"synonyms":["E-7389","E7389","Eribulin mesilate","Eribulin mesylate","Eribulin monomethanesulfonate","Halaven"],"crossReferences":{"DailyMed":["eribulin%20mesylate"],"chEBI":["70710"]},"count":18,"approvedIndications":["EFO_0003869","MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0006859","EFO_0000637","MONDO_0007254","MONDO_0004669","EFO_1001968","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_0000311","MONDO_0021632","EFO_0000304","EFO_1000044","EFO_0006861","MONDO_0002974","EFO_0005537","EFO_0008528","EFO_0000574","EFO_0000673","EFO_0006544","MONDO_0024880"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL1691","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1.Cl","inchiKey":"CHDPSNLJFOQTRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAXOLOL HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL423","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxolol","Betaxolol hydrochloride","Betoptic","Betoptic s","Kerlone"],"synonyms":["ALO 1401-02","ALO-1401-02","Betaxolol hydrochloride","SL 75.212-10","SL-75212-10"],"crossReferences":{"DailyMed":["betaxolol%20hydrochloride"],"PubChem":["26663050","50105931","855778"],"chEBI":["643228"]},"count":2,"approvedIndications":["EFO_0004190","EFO_1001069"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for open-angle glaucoma and ocular hypertension."}
{"id":"CHEMBL1697841","canonicalSmiles":"CNC(C)CCC=C(C)C","inchiKey":"XVQUOJBERHHONY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOMETHEPTENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Isometheptene"],"crossReferences":{"drugbank":["DB06706"]},"childChemblIds":["CHEMBL4303692","CHEMBL1327133","CHEMBL2105026","CHEMBL2355839"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1729","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC","inchiKey":"DCSUBABJRXZOMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CISAPRIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2000},"tradeNames":["Alimix","Prepulsid","Prepulsid quicklet","Propulsid","Propulsid quicksolv"],"synonyms":["Cisapride","Cisapride monohydrate","Propulsid","R-51,619","R-51619"],"crossReferences":{"PubChem":["144204250","170465200"],"Wikipedia":["Cisapride"]},"childChemblIds":["CHEMBL1200788"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0010282","EFO_1000948","EFO_0003917"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and is indicated for gastrointestinal disease. It was withdrawn in United States  in 2000 due to Cardiotoxicity."}
{"id":"CHEMBL1743013","drugType":"Antibody","blackBoxWarning":false,"name":"ENSITUXIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensituximab","NEO-101","NEO-102","NPC-1C"],"count":1,"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743020","drugType":"Antibody","blackBoxWarning":false,"name":"FORALUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Foralumab","NI-0401"],"count":2,"linkedTargets":{"rows":["ENSG00000167286","ENSG00000160654","ENSG00000198851"],"count":3},"linkedDiseases":{"rows":["EFO_0000384","EFO_0004599"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743065","drugType":"Antibody","blackBoxWarning":false,"name":"ROLEDUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Roledumab"],"linkedTargets":{"rows":["ENSG00000187010"],"count":1},"linkedDiseases":{"rows":["EFO_1001159"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL176","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"SKKLOUVUUNMCJE-FQSMHNGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEKANAMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminodeoxykanamycin","Bekanamycin","Bekanamycin sulfate","Kanamycin b","Kantrex","Klebcil","NK 1006","NK-1006"],"crossReferences":{"PubChem":["144206745"],"Wikipedia":["Bekanamycin"],"drugbank":["DB13673"],"chEBI":["28098"]},"childChemblIds":["CHEMBL1237048"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1789941","canonicalSmiles":"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1","inchiKey":"HFNKQEVNSGCOJV-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUXOLITINIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jakavi"],"synonyms":["INC-424","INC424","INCB-018424","INCB-18424","INCB018424","Ruxolitinib"],"crossReferences":{"DailyMed":["ruxolitinib%20phosphate"],"Wikipedia":["Ruxolitinib"],"drugbank":["DB08877"],"chEBI":["66919"]},"childChemblIds":["CHEMBL1795071","CHEMBL4594382","CHEMBL4594381"],"count":46,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_1001958","EFO_0005952","EFO_1000984","EFO_1001951","EFO_0000565","EFO_0004251","EFO_0000339","MONDO_0008903","EFO_0000676","MONDO_0015540","EFO_0004208","EFO_0000198","MONDO_0013730","EFO_0002618","EFO_0000466","EFO_0000220","EFO_0001642","EFO_0002429","MONDO_0008315","MONDO_0100096","EFO_0004192","HP_0004326","EFO_0000574","EFO_0001378","Orphanet_231214","MONDO_0009348","MONDO_0044903","MONDO_0004600","MONDO_0007254","EFO_0000209","EFO_0000274","EFO_0000305","EFO_0002430","EFO_0000183","EFO_1000726","EFO_1000042","EFO_1000388","EFO_0000479","EFO_1000253","EFO_0000616","EFO_0000694","EFO_0000685","EFO_1001779","MONDO_0019457","EFO_0000222","EFO_0004599","EFO_0003060","EFO_0000311","EFO_1000738","EFO_0001068","EFO_0000095","EFO_0000764","EFO_1001467","MONDO_0024880","EFO_0000181","EFO_0000519","EFO_1000494"],"count":57},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for neoplasm and cancer and has 44 investigational indications."}
{"id":"CHEMBL1823817","canonicalSmiles":"COC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(C(=O)NCC3(O)CCCCCC3)c2)c1=O","inchiKey":"FUCKCIVGBCBZNP-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CE-224535","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CE 224,535","CE-224,535","Ce-224535"],"crossReferences":{"drugbank":["DB12113"]},"count":2,"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL186007","canonicalSmiles":"Oc1ccccc1Br","inchiKey":"VADKRMSMGWJZCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Bromo-Phenol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Bromo-Phenol","2-Bromophenol","O-Bromophenol"],"crossReferences":{"drugbank":["DB04586"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908324","canonicalSmiles":"C=N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12)c1ccccc1","inchiKey":"FZECHKJQHUVANE-MCYUEQNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAMPICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metampicillin"],"crossReferences":{"drugbank":["DB13836"],"chEBI":["52060"]},"childChemblIds":["CHEMBL3138613"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL191190","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(Br)cc1","inchiKey":"BDVAWAILQCYMQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08281"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1956285","canonicalSmiles":"Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1","inchiKey":"OIZSVTOIBNSVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DSM-265","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSM265","Dsm-265","Dsm265"],"crossReferences":{"drugbank":["DB12397"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1964120","drugType":"Enzyme","blackBoxWarning":false,"name":"TALIGLUCERASE ALFA","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elelyso"],"synonyms":["PRGC-D","PRGCD","PRX-112","Taliglucerase alfa"],"crossReferences":{"DailyMed":["taliglucerase%20alfa"],"DrugCentral":["5199"]},"count":1,"approvedIndications":["Orphanet_355"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for gaucher disease."}
{"id":"CHEMBL1972860","canonicalSmiles":"CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1","inchiKey":"BKJIXTWSNXCKJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELESCLOMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elesclomol","GSK-842879","GSK-842879A","STA-4783"],"crossReferences":{"PubChem":["137275831","445356"],"Wikipedia":["Elesclomol"],"drugbank":["DB05719"],"chEBI":["79369"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL197669","canonicalSmiles":"CCCCc1nc(N)c2nc(-n3nccn3)n(C)c2n1","inchiKey":"CYYQMAWUIRPCNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ST1535","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST-1535","St1535"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062343","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"DUIFOMJYEIAMGH-RNSMDNJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2062343","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201319","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103824","canonicalSmiles":"CC(=O)NCCOC(=O)[C@H](Oc1cccc(C(F)(F)F)c1)c1ccc(Cl)cc1","inchiKey":"BJBCSGQLZQGGIQ-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARHALOFENATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arhalofenate","CB-102","CB102","JNJ-39659100","M-102","M102","MBX-102"],"crossReferences":{"drugbank":["DB11811"]},"count":2,"linkedTargets":{"rows":["ENSG00000197891","ENSG00000132170"],"count":2},"linkedDiseases":{"rows":["EFO_0004274","EFO_0001360"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103936","canonicalSmiles":"CCC[C@@]1(CCc2ccccc2)CC([O-])=C([C@H](CC)c2cccc([N-]S(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1.[Na+].[Na+]","inchiKey":"ZBWMQTUSVWBMQE-KPHXKKTMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPRANAVIR DISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL222559","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-140690E","Tipranavir disodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104393","canonicalSmiles":"O=c1c(I)cn(CC(O)CO)cc1I","inchiKey":"TZADDXVKYWMEHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPYDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iopydol"],"crossReferences":{"drugbank":["DB13389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104414","canonicalSmiles":"CCc1c(CC)c2cc3nc(cnc4cc(OCCOCCOCCOC)c(OCCOCCOCCOC)cc4ncc4nc(cc1[nH]2)C(CCCO)=C4C)C(C)=C3CCCO","inchiKey":"AHNIKTNNZJNCFN-CNEPGKQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTEXAFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Motexafin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104521","canonicalSmiles":"C[C@@H]1C[C@@H](OC(=O)c2cccnc2)CC(C)(C)C1","inchiKey":"GQSGZTBDVNUIQS-DGCLKSJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CICLONICATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciclonicate"],"crossReferences":{"drugbank":["DB13709"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104765","canonicalSmiles":"C[C@H](O)C(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"JUNDJWOLDSCTFK-MTZCLOFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMEGESTONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RU 27987","RU-27987","Trimegestone"],"crossReferences":{"drugbank":["DB13129"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104790","canonicalSmiles":"COc1ccccc1OCC1CNC(=O)O1","inchiKey":"ZMNSRFNUONFLSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENOXALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lenetran"],"synonyms":["Mephenoxalone"],"crossReferences":{"PubChem":["144206700","170466491"],"drugbank":["DB13754"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104864","canonicalSmiles":"O=C(O)/C=C/C(=O)O.O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1","inchiKey":"GELJVTSEGKGLDF-QDSMGTAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APLINDORE FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aplindore fumarate","DAB-452","Palindore","Palindore fumarate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104921","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2ccc(NC(c3c(C)n(C)n(-c4ccccc4)c3=O)S(=O)(=O)O)cc2)nn1","inchiKey":"BGLHAKAJGYLSOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfamazone"],"crossReferences":{"drugbank":["DB13556"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104932","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C(F)(F)F)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"CDZJOBWKHSYNMO-SCUQKFFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMEDROXONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumedroxone","WG 537 [AS ACETATE]"],"crossReferences":{"drugbank":["DB13610"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104981","canonicalSmiles":"COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1","inchiKey":"NNBGCSGCRSCFEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILAPLADIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rilapladib","SB-659032"],"crossReferences":{"drugbank":["DB05119"]},"count":2,"linkedTargets":{"rows":["ENSG00000146070"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","EFO_0000249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105075","canonicalSmiles":"O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12","inchiKey":"APQPGQGAWABJLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLOCTAFENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Idarac"],"synonyms":["Floctafenine","R 4318","RU 15750"],"crossReferences":{"PubChem":["170465681"],"drugbank":["DB08976"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105686","canonicalSmiles":"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1.CS(=O)(=O)O","inchiKey":"IXPBPUPDRDCRSY-YLZLUMLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENICRIVIROC MESYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2110727","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenicriviroc mesilate","Cenicriviroc mesylate","TAK-652","TBR-652"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105687","canonicalSmiles":"CCCN[C@@H]1CCc2nc(N)sc2C1.Cl.Cl.O","inchiKey":"APVQOOKHDZVJEX-LSBIWMFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPRAMIPEXOLE DIHYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL249420","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexpramipexole dihydrochloride","Dexpramipexole dihydrochloride monohydrate","KNS-760704","KNS-760704 ANHYDROUS","Pramipexole related compound d","SND 919CL2X","SND-919CL2X","SND-919CL2X MONOHYDRATE"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105737","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1","inchiKey":"VZZJRYRQSPEMTK-CALCHBBNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SONIDEGIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Erismodegib","LDE 225","LDE-225","LDE225","NVP-LDE 225","NVP-LDE-225","NVP-LDE225","Sonidegib"],"crossReferences":{"DailyMed":["sonidegib%20phosphate"],"drugbank":["DB09143"]},"childChemblIds":["CHEMBL3137317"],"count":13,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000616","EFO_0003869","EFO_0002618","MONDO_0040677","MONDO_0008170","MONDO_0007254","MONDO_0005341","MONDO_0007576","EFO_0002939","MONDO_0008315","EFO_0000565","EFO_0001421","EFO_0001378","EFO_0004193"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for neoplasm and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106220","canonicalSmiles":"CCC(=O)N(CC(C)N(C)CCc1ccccc1)c1ccccc1","inchiKey":"RXTHKWVSXOIHJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMPROMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diampromide"],"crossReferences":{"drugbank":["DB01502"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106309","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"MFBMYAOAMQLLPK-FZNHGJLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE ACEPONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydrocortisone aceponate"],"crossReferences":{"drugbank":["DB14538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107333","canonicalSmiles":"COC(=O)/C=C/C(=O)OC","inchiKey":"LDCRTTXIJACKKU-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL FUMARATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tecfidera"],"synonyms":["AZL 0 211089","AZL O 211089","AZL-0211089","AZL-O-211089","BG 00012","BG 12","BG-00012","BG-12","BG00012","Dimethyl fumar","Dimethyl fumarate","FAG-201","FP-187","FP187","Fumaric acid dimethyl ester","LAS-41008","LAS41008","Las41008","NSC-167432","NSC-25942"],"crossReferences":{"DailyMed":["dimethyl%20fumarate"],"drugbank":["DB08908"],"chEBI":["76004"]},"count":12,"approvedIndications":["EFO_0003885","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000079999"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000685","EFO_0003840","EFO_0008520","EFO_0000095","EFO_0001365","EFO_0002913","EFO_1001465","EFO_0000676","EFO_0003929","EFO_0003778","EFO_0000540","EFO_0003918"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for immune system disease and multiple sclerosis and has 10 investigational indications."}
{"id":"CHEMBL2107873","drugType":"Protein","blackBoxWarning":false,"name":"VONICOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAX 111","BAX-111","Von willebrand factor (recombinant)","Vonicog alfa"],"crossReferences":{"DrugCentral":["5173"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108058","drugType":"Protein","blackBoxWarning":false,"name":"VANUTIDE CRIDIFICAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACC-001","Vanutide cridificar"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108278","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ETEPLIRSEN","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exondys 51"],"synonyms":["AVI-4658","Eteplirsen"],"crossReferences":{"DailyMed":["eteplirsen"],"DrugCentral":["5182"]},"count":1,"approvedIndications":["Orphanet_98896"],"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2016 and is indicated for duchenne muscular dystrophy."}
{"id":"CHEMBL2108291","drugType":"Protein","blackBoxWarning":false,"name":"METENKEFALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metenkefalin","NSC-374896"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108557","drugType":"Protein","blackBoxWarning":false,"name":"TELBERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RH VEGF","RH-VEGF","RHVEG-F","RHVEGF","SNN0029","Telbermin"],"count":2,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755"],"count":2},"linkedDiseases":{"rows":["EFO_1001459","EFO_0000253"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108816","drugType":"Unknown","blackBoxWarning":false,"name":"YELLOW FEVER VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Yf-vax"],"synonyms":["FLAVIVIRUS YELLOW FEVER VIRUS 17D-204 WHOLE","Yellow fever vaccine","Yellow fever, live attenuated"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109092","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marogen","Neorecormon","Neorecormon 1000","Neorecormon 10000","Neorecormon 2000","Neorecormon 20000","Neorecormon 3000","Neorecormon 30000","Neorecormon 4000","Neorecormon 500","Neorecormon 5000","Neorecormon 6000","Recormon 1000","Recormon 10000","Recormon 2000","Recormon 5000","Recormon s 1000","Recormon s 10000","Recormon s 2000","Recormon s 5000"],"synonyms":["BM 06.019","EPOCH","Epoetin beta","Erythropoietin"],"crossReferences":{"DrugCentral":["5160"]},"count":39,"approvedIndications":["EFO_0004272"],"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0007405","EFO_0000401","EFO_1001919","MONDO_0002135","EFO_1002048","EFO_0003964","EFO_0005676","MONDO_0002158","EFO_0004247","EFO_0002506","EFO_1001375","EFO_1000824","EFO_0003144","EFO_0003884","MONDO_0005299","EFO_1000632","EFO_0004272","EFO_0000253","EFO_0007332","EFO_0000183","EFO_0003917","EFO_0009321","EFO_0000198","EFO_0006859","EFO_0003928","HP_0002140","EFO_1001330","EFO_1001779","EFO_0008572","EFO_0002687","HP_0001919","MONDO_0008170","EFO_0002508","EFO_0000403","EFO_1000782","EFO_0004599","EFO_0000311","EFO_0000546","EFO_0003885","MP_0001914","EFO_0004220","EFO_0000713","EFO_0001061","EFO_0001068","EFO_1001100","EFO_0000764","EFO_0004273","EFO_0000574","EFO_0008583","EFO_0001425","EFO_0000612","MONDO_0043510"],"count":52},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 38 investigational indications."}
{"id":"CHEMBL2109217","drugType":"Unknown","blackBoxWarning":false,"name":"PERFLUTREN PROTEIN-TYPE A MICROSPHERES","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Perflutren protein-type a microspheres"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109440","drugType":"Antibody","blackBoxWarning":false,"name":"LY-2787106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2787106","LY2787106","Ly-2787106"],"count":1,"linkedTargets":{"rows":["ENSG00000105697"],"count":1},"linkedDiseases":{"rows":["EFO_0004272"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109444","drugType":"Antibody","blackBoxWarning":false,"name":"AD-159","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-159"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109457","drugType":"Antibody","blackBoxWarning":false,"name":"LIGELIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ligelizumab","QGE-031","QGE031"],"count":6,"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","EFO_0007425","EFO_0000270","EFO_0000274","MONDO_0004784","EFO_0003785","EFO_1001881","EFO_0007187"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109564","drugType":"Antibody","blackBoxWarning":false,"name":"CL-184","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL-184","CR-57/CR-4098","Cl-184","MIX OF CR-57 AND CR-4098"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109646","drugType":"Antibody","blackBoxWarning":false,"name":"REGN-1154","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-1154"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110563","drugType":"Small molecule","blackBoxWarning":false,"name":"CYANOCOBALAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Behepan","Berubigen","Betalin 12","Calomist","Cobavite","Cyanocobalamin","Cyanovit-b12","Cytacon","Cytamen","Dodex","Nascobal","Redisol","Rubivite","Rubramin","Rubramin pc","Ruvite","Vi-twel","Vibalt","Vibisone","Vitamin B 12"],"synonyms":["Cyanocobalamin","Cycobemin","NSC-80365","Vitamin b12","Vitamin b12 nos"],"crossReferences":{"DailyMed":["cyanocobalamin"],"DrugCentral":["4196"]},"childChemblIds":["CHEMBL2096655","CHEMBL2104381","CHEMBL2104118"],"count":39,"approvedIndications":["EFO_0003884","EFO_0004272","EFO_0001360","EFO_0003882","EFO_0001070","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 approved and 33 investigational indications."}
{"id":"CHEMBL2110585","canonicalSmiles":"CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1","inchiKey":"GWEJFLVSOGNLSS-WPFOTENUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZATIOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ezatiostat","TLK-199"],"crossReferences":{"drugbank":["DB05460"]},"childChemblIds":["CHEMBL2103810"],"count":1,"linkedTargets":{"rows":["ENSG00000084207"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0001475","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110636","canonicalSmiles":"CCCC(=O)Nc1c(I)cc(I)c(/C=C(\\CC)C(=O)O)c1I","inchiKey":"CWRBDUIQDIHWJZ-SOFGYWHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUNAMIODYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bunamiodyl"],"crossReferences":{"drugbank":["DB04814"]},"childChemblIds":["CHEMBL2104558"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110900","canonicalSmiles":"CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1","inchiKey":"USRHYDPUVLEVMC-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPOXETINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dapoxetine","LY-210448"],"crossReferences":{"PubChem":["170466555"],"drugbank":["DB04884"]},"childChemblIds":["CHEMBL2106574"],"count":2,"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2146089","canonicalSmiles":"CC[C@H](NC(=O)c1c(O)c(-c2ccccc2)nc2ccccc12)c1ccccc1.Cl","inchiKey":"BHCSUEHQURQVLD-BDQAORGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALNETANT HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL10188","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-223412-A","Talnetant hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2205230","canonicalSmiles":"CCc1cc2c(c(OCC(F)(F)F)c(C(=O)NC3CCN(C(=O)CO)CC3)n2C)c(=O)n1CC(=O)c1ccccc1","inchiKey":"ZADWXQMNNVICKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-441","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-441"],"count":1,"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0004193"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL224325","canonicalSmiles":"Cc1ccc2c(Cl)cc(Cl)c(O)c2n1","inchiKey":"GPTXWRGISTZRIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORQUINALDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Steroxin"],"synonyms":["Chlorquinaldol","Clorquinaldol"],"crossReferences":{"PubChem":["124891968","144207039","170465701","26749812","29215181","89854495"],"Wikipedia":["Chlorquinaldol"],"drugbank":["DB13306"],"chEBI":["74500"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL227711","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-NYYOCOOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227711","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02421"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2304041","canonicalSmiles":"C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O","inchiKey":"BFZKMNSQCNVFGM-UCEYFQQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAGOPILONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY86-5302","DE-03757","Sagopilone","ZK 219477","ZK-219477"],"crossReferences":{"drugbank":["DB12391"]},"count":10,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0003893","EFO_0000756","EFO_0000702","MONDO_0007254","MONDO_0008315","EFO_0003060","EFO_0000519","EFO_1000158"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2337271","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2.Cl.O","inchiKey":"HLJIZAKUNCTCQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DONEPEZIL HYDROCHLORIDE MONOHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Donepezil Hydrochloride Monohydrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2338801","canonicalSmiles":"O=c1[nH]nc(CCc2ccc(C(F)(F)F)cc2)cc1O","inchiKey":"QBQMUMMSYHUDFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUVADAXISTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Luvadaxistat","Tak-831"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2358147","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"TVPJGGZLZLUPOB-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPHENAZINE MALEATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201328","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proketazine"],"synonyms":["Carphenazine","Carphenazine maleate","WY-2445"],"crossReferences":{"PubChem":["144206284"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2361425","canonicalSmiles":"Cl.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1","inchiKey":"YAUBKMSXTZQZEB-VROPFNGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2361425","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1734","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206192"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364629","canonicalSmiles":"N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.O.O.O.O=S(=O)(O)O","inchiKey":"SOGUOEZRYKUOHR-CQZKMDJHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEGEPANT SULFATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2178422","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nurtec odt"],"synonyms":["Rimegepant sulfate"],"crossReferences":{"DailyMed":["rimegepant%20sulfate"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for migraine disorder."}
{"id":"CHEMBL2402737","canonicalSmiles":"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F","inchiKey":"TVTXCJFHQKSQQM-LJQIRTBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDASANUTLIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idasanutlin","RG-7388","RG7388","RO-5503781","RO5503781"],"crossReferences":{"drugbank":["DB12325"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2448612","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O","inchiKey":"CJMJLDQKTOJACI-SEUSHGJOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ERGOTAMINE TARTRATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL442","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cafergot","Ergomar","Ergostat","Femergin","Gynergen","Lingraine","Medihaler ergotamine","Migril","Wigrettes"],"synonyms":["Ergotamine tartrate"],"crossReferences":{"DailyMed":["ergotamine%20tartrate"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000179546","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":7},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948 and is indicated for migraine disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL260091","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO","inchiKey":"FQYBTYFKOHPWQT-VGSWGCGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHIR-090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-090"],"crossReferences":{"drugbank":["DB07536"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265502","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1","inchiKey":"FIAFUQMPZJWCLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURAMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-34936","Suramin"],"crossReferences":{"PubChem":["11114098","124887029","144205598","170466101","26752197","26756673","50104860","544513","90341387"],"Wikipedia":["Suramin"],"drugbank":["DB04786"],"chEBI":["45906"]},"childChemblIds":["CHEMBL413376"],"count":1,"linkedTargets":{"rows":["ENSG00000113578"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","DOID_10113","EFO_0005044","HP_0001919","EFO_0000681","MONDO_0007254","EFO_0003060","MONDO_0008315","EFO_1001951","MONDO_0001187","EFO_0007294","EFO_0000673","EFO_0006544","EFO_0001378","EFO_1000796","EFO_1000158"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL266195","canonicalSmiles":"C=CCc1ccccc1OCC(O)CNC(C)C","inchiKey":"PAZJSJFMUHDSTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPRENOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alprenolol"],"crossReferences":{"PubChem":["104171111","124879296","144203635","170465812","26752306","50105225","50105226","90340777"],"Wikipedia":["Alprenolol"],"drugbank":["DB00866"],"chEBI":["51211"]},"childChemblIds":["CHEMBL3249366","CHEMBL1256179"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL270527","canonicalSmiles":"O=C(C1CCN(c2ccncc2)CC1)N1CCN(S(=O)(=O)c2ccc3cc(Cl)ccc3c2)CC1","inchiKey":"ZLAKCKVFSRSENR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL270527","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01836"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280998","canonicalSmiles":"Oc1ccccc1O","inchiKey":"YCIMNLLNPGFGHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CATECHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrocatechol"],"crossReferences":{"PubChem":["11111004","144209515","144210473","17389988","50105556","57264281","85230987","90341698"],"Wikipedia":["Catechol"],"drugbank":["DB02232"],"chEBI":["18135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289233","canonicalSmiles":"COc1ccc2[nH]c(I)c(CCNC(C)=O)c2c1","inchiKey":"FJDDSMSDZHURBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOMELATONIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Iodomelatonin","Iodomelatonin"],"crossReferences":{"PubChem":["11111317","11113672","26751858"],"drugbank":["DB08190"]},"childChemblIds":["CHEMBL1788358"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292303","canonicalSmiles":"N[C@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"QIVBCDIJIAJPQS-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-TRYPTOPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Trp","D-Tryptophan"],"crossReferences":{"PubChem":["144204756","144211617","170465485","26753353"],"drugbank":["DB03225"],"chEBI":["16296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039513","canonicalSmiles":"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F","inchiKey":"ASUGUQWIHMTFJL-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECERNOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adelatinib","Decernotinib","VRT-831509","VX-509"],"crossReferences":{"drugbank":["DB12566"]},"count":1,"linkedTargets":{"rows":["ENSG00000105639"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3093499","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CCCC(=O)O)C2CCCCC2)[C@H](O)[C@H](C)O1","inchiKey":"CZXGBIFEWYVYJY-NPLULESDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-377202","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-377202","L-377202-000H"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3126842","canonicalSmiles":"COc1ccc2c(c1)[C@@H]1C[C@]1(C(=O)N1C3CCC1CN(C)C3)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)N(C)C)cc21","inchiKey":"ZTTKEBYSXUCBSE-VSBZUFFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECLABUVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-791325","Beclabuvir"],"childChemblIds":["CHEMBL3137325"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL313113","canonicalSmiles":"CCOC/C=C/c1ccc(-c2nc(-c3ccc(NC(C)C)cc3)c(-c3ccc(NC(C)C)cc3)[nH]2)cc1","inchiKey":"RSJCLODJSVZNQA-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL313113","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14069"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL316966","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O","inchiKey":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIC ADENOSINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camp","Cyclic Adenosine Monophosphate","cyclic AMP"],"crossReferences":{"PubChem":["144207059","50105813","90340992"],"Wikipedia":["Cyclic_adenosine_monophosphate"],"drugbank":["DB02527"],"chEBI":["17489"]},"childChemblIds":["CHEMBL1363683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186453","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccncc1","inchiKey":"BQTXJHAJMDGOFI-NJLPOHDGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466851"],"drugbank":["DB11487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187246","canonicalSmiles":"CN(C)CCN(Cc1cccs1)c1ccccn1.CN(C)CCN(Cc1cccs1)c1ccccn1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"OLGIEIJNOQGBSS-VQYXCCSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAPYRILENE FUMARATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1411979","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"],"classes":["Carcinogenicity"],"year":1979},"tradeNames":[],"synonyms":["Methapyrilene fumarate"],"crossReferences":{"PubChem":["144213936"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States and  Germany initially in 1979 due to Carcinogenicity."}
{"id":"CHEMBL321357","canonicalSmiles":"NCC[C@H](N)C(=O)O","inchiKey":"OGNSCSPNOLGXSM-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252925"],"drugbank":["DB03817"],"chEBI":["48950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL327579","canonicalSmiles":"CC(C)(C)OC(=O)Nc1cccnc1C(=O)Nc1nccs1","inchiKey":"QBMYJIFXSXKPFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07902"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3306803","canonicalSmiles":"CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12","inchiKey":"HOIIHACBCFLJET-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMATEPERONE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ITI 007","ITI-007","ITI-722","ITI007","Lumateperone"],"crossReferences":{"DailyMed":["lumateperone%20tosylate"],"drugbank":["DB06077"]},"childChemblIds":["CHEMBL3233142"],"count":3,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000249","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 investigational indications."}
{"id":"CHEMBL3391771","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.[Cl-].[Cl-]","inchiKey":"SGTJOJSPEWDARP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3391771","maximumClinicalTrialPhase":0,"parentId":"CHEMBL703","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3436365","canonicalSmiles":"O=C(O)/C=C\\C(=O)O.O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1","inchiKey":"OAUUYDZHCOULIO-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3436365","maximumClinicalTrialPhase":0,"parentId":"CHEMBL219916","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["59812"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL345524","canonicalSmiles":"O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12","inchiKey":"NWGGKKGAFZIVBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTRAFENINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"year":1984},"tradeNames":[],"synonyms":["Antrafenine"],"crossReferences":{"Wikipedia":["Antrafenine"],"drugbank":["DB01419"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984."}
{"id":"CHEMBL3544913","canonicalSmiles":"NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1","inchiKey":"JESCETIFNOFKEU-SJORKVTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIXOTRIGINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-074","BIIB074","CNV-1014802","CNV1014802","GSK-1014802","GSK1014802","Raxatrigine","Vixotrigine"],"crossReferences":{"drugbank":["DB11706"]},"childChemblIds":["CHEMBL3544912"],"count":6,"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","EFO_0000289","EFO_1001219","Orphanet_1956","MONDO_0002959","EFO_0009878"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3544942","drugType":"Small molecule","blackBoxWarning":false,"name":"RONICICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY10-00394","Bay-1000394","Roniciclib"],"count":3,"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000135446","ENSG00000155111","ENSG00000105810","ENSG00000167258","ENSG00000059758","ENSG00000136807","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000117266","ENSG00000132964","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544979","drugType":"Small molecule","blackBoxWarning":false,"name":"IMISOPASEM MANGANESE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["403","GC-4403","Imisopasem manganese","M 40403","M-40403","M40403","SC-72325"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544982","canonicalSmiles":"COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1.Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"GQLLAIBEWDUUBQ-QIYAQLFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESEVATINIB TOSYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3544983","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tesevatinib tosylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545154","canonicalSmiles":"C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1","inchiKey":"LPFWVDIFUFFKJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POZIOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM 781-36","HM 781-36B","HM-781-36","HM-781-36B","Hm-781-36b","NOV-120101","Poziotinib"],"crossReferences":{"drugbank":["DB12114"]},"count":8,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361","ENSG00000178568","ENSG00000141736"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0005922","HP_0020174","EFO_0000571","EFO_0004284","MONDO_0007254","EFO_0003060","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545194","drugType":"Small molecule","blackBoxWarning":false,"name":"LGH-447","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGH-447","LGH447","Lgh-447","NVP-LGH477","PIM 447","PIM-447"],"count":3,"linkedTargets":{"rows":["ENSG00000102096","ENSG00000137193","ENSG00000198355"],"count":3},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000222","EFO_0001378"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545199","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7741","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0575","Rg-7741"],"count":1,"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545874","canonicalSmiles":"N[C@@H](C(=O)N[C@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1","inchiKey":"JAPHQRWPEGVNBT-IJLUTSLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3545874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04293"]},"childChemblIds":["CHEMBL3348864"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL355048","canonicalSmiles":"CC(C)N(C(=O)c1ccc(Cl)cc1Cl)c1cc(-c2ccccc2)sc1C(=O)O","inchiKey":"UKNZREOUDLFUFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL355048","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3590674","canonicalSmiles":"O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1","inchiKey":"AGPIHNZOZNKRGT-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-639","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-639"],"crossReferences":{"drugbank":["DB15055"]},"childChemblIds":["CHEMBL3589557"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3663929","canonicalSmiles":"C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1","inchiKey":"QKDCLUARMDUUKN-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAQUOTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-8273","ASP8273","Naquotinib"],"crossReferences":{"drugbank":["DB12036"]},"childChemblIds":["CHEMBL3707350"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707372","canonicalSmiles":"CC[C@H]1[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C3(C)CC3)C[C@H]2C(C)C)N2C[C@@H]1Oc1nc3cc(OC)ccc3nc1C(F)(F)CCCC[C@@H]1C[C@H]1OC(=O)N[C@@H](C(C)(C)C)C2=O","inchiKey":"MKDALIOACIEUJM-XCFCBFDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXILAPREVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-9857","Voxilaprevir"],"crossReferences":{"DailyMed":["voxilaprevir"]},"count":3,"approvedIndications":["EFO_0004220"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chronic hepatitis c virus infection and has 2 investigational indications."}
{"id":"CHEMBL3833373","drugType":"Antibody","blackBoxWarning":false,"name":"AVELUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C"],"crossReferences":{"DailyMed":["avelumab"]},"count":60,"approvedIndications":["EFO_0000616","EFO_1001471","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000228","EFO_1001951","Orphanet_178","EFO_0000339","EFO_0000564","EFO_0000096","EFO_0000588","EFO_0000182","EFO_0008528","Orphanet_2495","MONDO_0018352","EFO_0002618","EFO_0005922","MONDO_0008170","MONDO_0008315","MONDO_0015917","EFO_1000576","EFO_0000574","EFO_0001378","EFO_0000292","EFO_1001901","MONDO_0007254","EFO_0004252","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_0000231","MONDO_0001187","EFO_1001480","MONDO_0002158","EFO_0003968","EFO_0000196","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0006859","EFO_0000503","Orphanet_59305","EFO_0000403","MONDO_0007576","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0003863","EFO_1001471","MONDO_0002529","EFO_1000581","MONDO_0002120","EFO_0002517","MONDO_0011962","EFO_0004142","EFO_0000702","MONDO_0018906","MONDO_0024880","EFO_0000181","EFO_0000519"],"count":63},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 57 investigational indications."}
{"id":"CHEMBL392452","canonicalSmiles":"CC(C)[C@H]1SC(Nc2ccccc2F)=NC1=O","inchiKey":"OJJBBNIYQKFZDK-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL392452","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989510","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.Cl","inchiKey":"OQGYMIIFOSJQSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAZOCINE HYDROCHLORIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL100116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sosegon","Talwin","Talwin 50"],"synonyms":["Pentazocine hydrochloride"],"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and is indicated for pain."}
{"id":"CHEMBL3989756","canonicalSmiles":"O.O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O","inchiKey":"FPAFDBFIGPHWGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALC","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3990276","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sclerosol","Steritalc","Talc"],"synonyms":["E-553(III)","INS NO.553(III)","INS-553(III)","Talc"],"crossReferences":{"DailyMed":["talc"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 investigational indications."}
{"id":"CHEMBL3989985","drugType":"Enzyme","blackBoxWarning":false,"name":"RIBAXAMASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P3A","Ribaxamase","SYN-004"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL403772","canonicalSmiles":"CC(C)(C)c1nnc(C(=O)[C@@H]2CCCN2)o1","inchiKey":"YUKGJYBQODPVBL-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403772","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL40422","canonicalSmiles":"CC(C)C[C@H](N)P(=O)(O)O","inchiKey":"HGCAUCAWEADMPM-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCINE PHOSPHONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leucine Phosphonic acid"],"crossReferences":{"drugbank":["DB02386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL406734","canonicalSmiles":"COC(=O)[C@H](Cc1ccc(Br)cc1)NC(=O)CCCCCCC(=O)NO","inchiKey":"UPYGSQPRAHMDPD-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL406734","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4082191","canonicalSmiles":"[2H]c1cc(C(=O)NC([2H])([2H])[2H])c(F)c([2H])c1N1C(=S)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=O)C12CCC2","inchiKey":"HJBWBFZLDZWPHF-VMHMUCGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4082191","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3183409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411278","canonicalSmiles":"C[C@]12C[C@@]34C=CC(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2","inchiKey":"CSOMAHTTWTVBFL-OFBLZTNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL411278","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08407"],"chEBI":["68236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4112930","canonicalSmiles":"C[C@]12CCCN1Cc1n[nH]c(=O)c3cc(F)cc4[nH]c2c1c43","inchiKey":"DENYZIUJOTUUNY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-290","Bgb-290","Pamiparib"],"crossReferences":{"drugbank":["DB14769"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4204794","canonicalSmiles":"Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1","inchiKey":"DWYRIWUZIJHQKQ-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVAPRITINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ayvakit"],"synonyms":["70C366","Avapritinib","BLU-285","C-366","X-720776","X720776"],"crossReferences":{"DailyMed":["avapritinib"],"drugbank":["DB15233"]},"count":3,"approvedIndications":["Orphanet_44890"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000157404"],"count":2},"linkedDiseases":{"rows":["EFO_0007359","Orphanet_44890","MONDO_0016586"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for gastrointestinal stromal tumor and has 2 investigational indications."}
{"id":"CHEMBL4297222","canonicalSmiles":"CS(=O)(=O)O.Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1.O.O.O","inchiKey":"HCKBCMVQGLVGEA-ZBFDXWMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAZARTINIB MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3787344","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NVP-EGF816-AGA","Nazartinib mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297239","drugType":"Cell","blackBoxWarning":false,"name":"DILANUBICEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dilanubicel","NLA101"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297410","drugType":"Small molecule","blackBoxWarning":false,"name":"IT-139","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["It-139","KP-1339","NKP-1339","Nkp-1339"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297413","canonicalSmiles":"FC(F)(F)C(C(F)(F)F)(C(F)(F)F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F","inchiKey":"VLTXBOGHSBHSAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFLUORO TERT-BUTYLCYCLOHEXANE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxycyte","Perfluoro tert-butylcyclohexane"],"crossReferences":{"drugbank":["DB12477"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297556","drugType":"Unknown","blackBoxWarning":false,"name":"MM-111","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mm 111","Mm-111"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297708","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986258","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986258","Bms-986258","ONO-7807"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297813","drugType":"Unknown","blackBoxWarning":false,"name":"PRI-724","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S,S)-ICG-001","PRI-724","PRI724","Pri-724"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297816","drugType":"Unknown","blackBoxWarning":false,"name":"PX-478","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Px 478","Px-478"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297831","drugType":"Antibody","blackBoxWarning":false,"name":"SPARTALIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-PD1 MONOCLONAL ANTIBODY PDR001","NVP-LZV184","PDR-001","PDR001","Pdr001","Spartalizumab"],"count":18,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL4297844","drugType":"Antibody","blackBoxWarning":false,"name":"TRASTUZUMAB DERUXTECAN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enhertu"],"synonyms":["DS-8201","DS-8201a","Ds-8201a","Fam-trastuzumab deruxtecan-nxki","Trastuzumab deruxtecan"],"count":7,"linkedTargets":{"rows":["ENSG00000198900","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0003869","EFO_0000637","EFO_0008549","EFO_1000238","MONDO_0007254","EFO_0004142","MONDO_0003219","MONDO_0024880","EFO_0000305","EFO_0003060","EFO_0009708"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 7 investigational indications."}
{"id":"CHEMBL4297893","drugType":"Unknown","blackBoxWarning":false,"name":"AGS62P1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGS62P1","ASP-1235","ASP1235","Ags62p1","Asp1235"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298008","drugType":"Unknown","blackBoxWarning":false,"name":"LYMPHOCYTE ACTIVATION GENE 3 PROTEIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lag-3","Lymphocyte activation gene 3 protein"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298024","drugType":"Unknown","blackBoxWarning":false,"name":"M-7824","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8L9YQ2N6PA","Bintrafusp alfa","M-7824","M7824","MSB-0011359C","MSB0011359C","Msb0011359c"],"count":11,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL4298063","drugType":"Unknown","blackBoxWarning":false,"name":"CILIARY NEUROTROPHIC FACTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciliary neurotrophic factor","Human cntf","Nt-501"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4303515","canonicalSmiles":"COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C.[Na+]","inchiKey":"NBTJODGYIZLGAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303515","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1219","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303541","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"DUIFOMJYEIAMGH-FNQJAENISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303541","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201319","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL444814","canonicalSmiles":"NC(=O)NCCC[C@H](N)C(=O)O","inchiKey":"RHGKLRLOHDJJDR-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-CITRULLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-citrulline"],"crossReferences":{"Wikipedia":["Citrulline"],"drugbank":["DB00155"],"chEBI":["16349"]},"childChemblIds":["CHEMBL4297667"],"count":13,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL458049","canonicalSmiles":"COc1ccc(CCC(=O)O)cc1OC","inchiKey":"LHHKQWQTBCTDQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dimethoxy-Hydrocinnamic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dimethoxy-Hydrocinnamic Acid","3,4-Dimethoxyhydrocinnamic Acid"],"crossReferences":{"PubChem":["26659733"],"drugbank":["DB04208"],"chEBI":["44235"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594448","canonicalSmiles":"CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1","inchiKey":"RENRQMCACQEWFC-UGKGYDQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPTACOPAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iptacopan","LNP-023","LNP023","Lnp023"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594502","drugType":"Unknown","blackBoxWarning":false,"name":"TAK-981","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-981","Tak-981"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL484","canonicalSmiles":"Nc1ncnc2c1ncn2CCOCP(=O)(O)O","inchiKey":"SUPKOOSCJHTBAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADEFOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adefovir","GS 0393","GS-0393"],"crossReferences":{"PubChem":["144205435","29216223"],"Wikipedia":["Adefovir"],"drugbank":["DB13868"]},"childChemblIds":["CHEMBL2386204"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL490225","canonicalSmiles":"CCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"QFAPUKLCALRPLH-UXXRCYHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02451"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL49563","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CCC(C)(CCCC(C)CCCC(C)CCCC(C)C)O2","inchiKey":"GVJHHUAWPYXKBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"alpha-TOCHOPHEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["225144220","26749212","50107544"],"drugbank":["DB14476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL497001","canonicalSmiles":"O=C1c2c(O)cccc2C([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21","inchiKey":"AFHJQYHRLPMKHU-CGISPIQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloin","Aloin A"],"crossReferences":{"Wikipedia":["Aloin"],"drugbank":["DB15477"],"chEBI":["73222"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL504802","canonicalSmiles":"O=C(O)C[C@H](NC(=O)CP(=O)(O)O)C(=O)O","inchiKey":"ZZKNRXZVGOYGJT-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sparfosic Acid"],"crossReferences":{"drugbank":["DB03459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506972","canonicalSmiles":"CCOC(=O)c1c(C)n[nH]c1C","inchiKey":"BCKARVLFIJPHQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL506972","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL518383","canonicalSmiles":"O=C(Nc1ccc(F)cc1)c1n[nH]cc1NC(=O)c1c(F)cccc1F","inchiKey":"BDRDBXXWQDFXEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL518383","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08138"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)O)cc1","inchiKey":"HEFNNWSXXWATRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUPROFEN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aches-n-pain","Advil","Advil liqui-gels","Advil migraine liqui-gels","Anadin joint pain","Anadin liquifast","Anadin period pain relief","Anadin ultra","Apsifen","Apsifen-f","Arthrofen 200","Arthrofen 400","Arthrofen 600","Brufen ret","Caldolor","Cap-profen","Children's advil","Children's advil-flavored","Children's elixsure","Children's ibuprofen","Children's motrin","Co-op","Codafen continus","Cuprofen for child","Cuprofen plus","Deep relief","Ebufac","Femafen","Fenbid","Fenbid fte","Fenpaed","Feverfen","Fleximex","Ibu-slo","Ibu-tab","Ibu-tab 200","Ibucalm","Ibuderm","Ibufac","Ibugel","Ibugel fte","Ibular","Ibuleve","Ibumed","Ibumetin","Ibumousse","Ibuprin","Ibuprofen","Ibuprohm","Ibuspray","Ibutime","Inabrin","Infant's advil","Inoven","Isisfen","Junifen","Junior strength advil","Junior strength ibuprofen","Junior strength motrin","Lidifen","Lidifen-f","Lobufen","Mandafen","Manorfen","Maxa-gesic","Medipren","Midol","Midol liquid gels","Migrafen","Motrin","Motrin ib","Motrin migraine pain","Novaprin","Nuprin","Nurofen 400","Nurofen back pain sr","Nurofen child","Nurofen for child","Nurofen plus","Nurofen recovery","Nurofen sinus","Nurofen solb","Orbifen","Pacifene","Paxofen","Pedea","Pediatric advil","Phensic","Phor pain","Phorpain","Phorpain max strgh","Profen","Proflex","Proflex sr","Relcofen","Rimafen","Rufen","Seclodin","Suspren","Tab-profen"],"synonyms":["IB-100","IP-82","Ibuprofen","M01AE01","NSC-256857","RD 13621","U-18,573","U-18573"],"crossReferences":{"DailyMed":["ibuprofen","ibuprofen%20lysine","ibuprofen%20sodium"],"PubChem":["104171175","124880372","124880375","138460","144203721","144208582","144213146","170464979","174007269","26747223","26747224","26752326","50105276","50105277","50105278","56422436","85231082","855602","90341584"],"TG-GATEs":["72"],"Wikipedia":["Ibuprofen"],"drugbank":["DB01050"],"chEBI":["5855"]},"childChemblIds":["CHEMBL4594450","CHEMBL1201141","CHEMBL3989408","CHEMBL1241153"],"count":72,"approvedIndications":["HP_0002829","EFO_0000685","HP_0003326","EFO_0002506","EFO_0003821","HP_0100607","EFO_0000319","HP_0003418","EFO_0007328","EFO_0003843","EFO_0005755","EFO_0005757","EFO_0002609"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001139","EFO_0007486","EFO_0009610","MONDO_0002009","EFO_0000249","HP_0001643","EFO_1001919","HP_0012228","HP_0011868","EFO_0003964","EFO_0006803","HP_0100543","EFO_0003103","EFO_0003931","EFO_0000771","EFO_0002506","EFO_0000544","EFO_0004263","EFO_1001366","EFO_0009582","EFO_0009093","EFO_1000786","EFO_0004616","EFO_1000632","HP_0003419","EFO_1000652","EFO_1000854","Orphanet_379","EFO_1001250","EFO_0005854","EFO_1001476","EFO_0001074","EFO_0005296","HP_0012532","EFO_0003821","EFO_0010072","Orphanet_3389","EFO_1000782","EFO_0009516","EFO_0005757","Orphanet_98896","EFO_0000546","MP_0001914","HP_0003326","MP_0001845","MONDO_0100096","EFO_0000731","HP_0030833","EFO_0003957","EFO_0001359","EFO_0004209","HP_0100607","EFO_0007328","MONDO_0002258","EFO_1001158","EFO_0000668","EFO_0003767","EFO_0003943","EFO_1000843","EFO_0002970","EFO_0006834","HP_0002373","Orphanet_232","MONDO_0024290","EFO_0000464","EFO_0005252","MONDO_0007254","EFO_1000637","EFO_0002950","HP_0004398","HP_0002829","Orphanet_70589","EFO_1001216","EFO_0003938","EFO_0004143","EFO_0005279","EFO_0003917","EFO_0000694","EFO_0000685","EFO_0000772","EFO_0005774","EFO_1001757","EFO_0003832","HP_0001945","EFO_0003958","EFO_0003929","EFO_0000319","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0007214","EFO_0002609","EFO_0005755","EFO_0000537","EFO_0003885","EFO_1001460","EFO_0001068","EFO_0000649","EFO_0000764","EFO_1001891","EFO_0000706","EFO_0005611","MONDO_0024880","EFO_0003918","EFO_0009615"],"count":107},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 13 approved and 59 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL526688","canonicalSmiles":"Cc1cc(N)nc(C[C@H]2CNC[C@@H]2NCCNCc2cccc(Cl)c2)c1","inchiKey":"VWCMAGONQJHIJZ-LPHOPBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL526688","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08019"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL533819","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12.Cl","inchiKey":"RSQUCTRNEAUEEW-DOELHFPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-125887","maximumClinicalTrialPhase":0,"parentId":"CHEMBL76370","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-125887"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54661","canonicalSmiles":"OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"NJMYODHXAKYRHW-DVZOWYKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPENTIXOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flupentixol","LC 44","LC-44","N-7009"],"crossReferences":{"PubChem":["144205556","170465964","26755684","29216405","50111069","50111070","90341514"],"drugbank":["DB00875"],"chEBI":["10454"]},"childChemblIds":["CHEMBL1496351","CHEMBL1256995"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL562967","canonicalSmiles":"CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C","inchiKey":"MLESJYFEMSJZLZ-MAAOGQSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ro5024048; r7128"],"synonyms":["3',5'-DIISOBUTYRYL PSI 6130","Mericitabine","PSI 6130 DIISOBUTYRATE","R 7128","R-7128","R7128","RG 7128","RO-5024048","RO5024048"],"crossReferences":{"drugbank":["DB12045"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL57375","canonicalSmiles":"O=C(Nc1nccs1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nccs4)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"JDALSSGOBMTZEP-NWJWHWDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL57375","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL576","canonicalSmiles":"O=C(O)CCC(=O)O","inchiKey":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E363","Succinic acid"],"crossReferences":{"PubChem":["144205165","144209116","144213564","170465738","29215296"],"Wikipedia":["Succinic_acid"],"drugbank":["DB00139"],"chEBI":["15741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL578390","canonicalSmiles":"CCCCCCCCC/C(=C\\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O","inchiKey":"AALSSIXXBDPENJ-FYWRMAATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APX-3330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX 3330","APX-3330","APX3330","Apx-3330","Apx3330","E 3330","E-3330"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL580","canonicalSmiles":"O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O","inchiKey":"DIWRORZWFLOCLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LORAZEPAM","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abbloraz","Ativan","Loraz","Lorazepam","Lorazepam intensol","Lorazepam preservative free","Temesta"],"synonyms":["Lorazepam","Lorazepam civ","NSC-289758","WY-4036"],"crossReferences":{"DailyMed":["lorazepam"],"PubChem":["144205222","29215381"],"Wikipedia":["Lorazepam"],"drugbank":["DB00186"]},"count":23,"approvedIndications":["EFO_0006788","EFO_0003761","EFO_0005230"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0004777","EFO_0002610","EFO_1000924","MONDO_0002009","HP_0000726","EFO_0000249","HP_0001268","EFO_0009267","EFO_1000800","HP_0002018","EFO_0003829","EFO_0000474","MONDO_0002050","EFO_0003761","HP_0002013","EFO_0004242","EFO_0005230","EFO_0000692","EFO_0008526","EFO_0006788","EFO_0009692","HP_0001250","MONDO_0004900","EFO_0003843","EFO_1001146","HP_0000713","EFO_1001892","EFO_0003890","EFO_0005411"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 3 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL58792","canonicalSmiles":"COc1ccccc1N1CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"IRYFCWPNDIUQOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUANISONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluanisone","MD 2028","R 2028","R 2167"],"crossReferences":{"PubChem":["144204543","7972459"],"Wikipedia":["Fluanisone"],"drugbank":["DB13665"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL6","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"CGIGDMFJXJATDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"INDOMETHACIN","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artracin","Artracin sr","Berlind 75 ret","Flexin-25 continus","Flexin-50 continus","Flexin-75 continus","Imbrilon","Indo-lemmon","Indo-paed","Indocid ret","Indocid-r","Indocin","Indocin sr","Indoderm","Indoflex","Indolar","Indolar sr","Indomax-25","Indomax-75 sr","Indomethacin","Indomod","Indoptol","Indotard mr 75","Ledmecin","Maximet sr","Mobilan","Pardelprin mr","Rheumacin la","Rimacid","Slo-indo","Tivorbex"],"synonyms":["Indometacin","Indometacin farnesil","Indomethacin","NSC-77541"],"crossReferences":{"DailyMed":["indomethacin"],"PubChem":["11111328","11111329","11113361","124880453","124880455","124880457","124880458","144206660","144208989","144210586","170464705","17389851","174007200","26747086","26747087","26751593","50100255","50104238","50104239","50126367","56422212","85231093","856012","90340917"],"TG-GATEs":["15"],"Wikipedia":["Indometacin"],"drugbank":["DB00328"],"chEBI":["49662"]},"childChemblIds":["CHEMBL2028292","CHEMBL3989410","CHEMBL4590319"],"count":30,"approvedIndications":["HP_0002829","HP_0003326","EFO_0002506","EFO_0004274","EFO_0003898","EFO_0000319","EFO_0003843","EFO_0005752","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1000172","EFO_1001896","MONDO_0003005","EFO_0000278","MONDO_0024290","EFO_0004274","HP_0001643","EFO_0000249","MONDO_0007254","EFO_0005252","EFO_1001951","HP_0002829","EFO_1000318","EFO_0002506","EFO_0009582","EFO_0000389","EFO_0000673","EFO_1000652","EFO_0000196","EFO_0003917","EFO_0005752","EFO_0010072","EFO_0003898","EFO_0000319","EFO_0003843","MONDO_0008315","EFO_0005755","MONDO_0012511","MP_0001914","HP_0003326","MP_0001845","EFO_1001412","MONDO_0100096","Orphanet_79292","EFO_0003965","EFO_0000270","EFO_0000199","EFO_0000342","EFO_0000181","MONDO_0024475"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 9 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL603","canonicalSmiles":"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12","inchiKey":"YEEZWCHGZNKEEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZAFIRLUKAST","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accolate","Zafirlukast"],"synonyms":["ICI 204,219","ICI-204219","Zafirlukast"],"crossReferences":{"DailyMed":["zafirlukast"],"PubChem":["144205729","170464673","26719823","26757966","49681658"],"Wikipedia":["Zafirlukast"],"drugbank":["DB00549"],"chEBI":["10100"]},"count":4,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0000270","MONDO_0008170","MONDO_0007254"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for asthma and airway obstruction and has 2 investigational indications."}
{"id":"CHEMBL659","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2","inchiKey":"ASUTZQLVASHGKV-JDFRZJQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GALANTAMINE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acumor xl","Consion xl","Elmino xl","Galsya xl","Galzemic xl","Gatalin xl","Gazylan xl","Lotprosin xl","Luventa xl","Reminyl","Reminyl xl","Zeebral xl"],"synonyms":["Galantamine","Galanthamine","NSC-100058","Razadyne"],"crossReferences":{"DailyMed":["galantamine%20hydrobromide"],"PubChem":["104171341","144204358","26751839"],"Wikipedia":["Galantamine"],"drugbank":["DB00674"],"chEBI":["42944"]},"childChemblIds":["CHEMBL4467191","CHEMBL1555","CHEMBL3099484"],"count":17,"approvedIndications":["HP_0000726"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","Orphanet_282","EFO_0002610","EFO_0004718","EFO_0004280","HP_0000726","EFO_0000249","EFO_1001905","EFO_0005252","EFO_0003758","EFO_0000677","EFO_0003768","EFO_0006792","EFO_0001073","EFO_0000195","HP_0100543","EFO_0001072","EFO_0000289","MONDO_0002050","EFO_0000713","Orphanet_79292","EFO_0004895","EFO_0000712","EFO_0000764","EFO_0005230","EFO_0000692","EFO_0005411"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for dementia and has 16 investigational indications."}
{"id":"CHEMBL684","canonicalSmiles":"CCN(CC)C(=O)N1CCN(C)CC1","inchiKey":"RCKMWOKWVGPNJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLCARBAMAZINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diethylcarbamazine","Hetrazan"],"crossReferences":{"Wikipedia":["Diethylcarbamazine"],"drugbank":["DB00711"],"chEBI":["4527"]},"childChemblIds":["CHEMBL937"],"count":4,"approvedIndications":["EFO_1001342"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for helminthiasis and has 3 investigational indications."}
{"id":"CHEMBL70972","canonicalSmiles":"CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O","inchiKey":"ZBVKEHDGYSLCCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERATRODAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-73001","AA-2414","ABBOTT-73001","ABT-001","Seratrodast"],"crossReferences":{"PubChem":["144206327","170465940","50125893"],"drugbank":["DB06739"]},"count":1,"linkedTargets":{"rows":["ENSG00000006638"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL851","canonicalSmiles":"O=C(O)CCc1ccccc1","inchiKey":"XMIIGOLPHOKFCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYL PROPIONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenyl propionic acid"],"crossReferences":{"PubChem":["144212646"],"drugbank":["DB02024"],"chEBI":["28631"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL97893","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFRUCTOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfructose"],"crossReferences":{"PubChem":["29218079"],"drugbank":["DB04551"],"chEBI":["28013"]},"childChemblIds":["CHEMBL3945772","CHEMBL2146112"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL99842","canonicalSmiles":"CC(=O)Nc1nccc(-c2c(C)nc3ccccn23)n1","inchiKey":"ZCRPPLDDHBLUES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL99842","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
